PTIE Soars 200%, RTRX On Track, All Eyes On EVFM, MCRB

Today's Daily Dose brings you news about Acasti Pharma and AtriCure's stock offering; near-term catalyst of Entasis, Evofem Biosciences, Neon Therapeutics and Seres, and updated results from Sarepta's Phase 1/2a gene therapy clinical trial in DMD.

from RTT - Biotech https://ift.tt/2ye23Yw
via IFTTT